Legato Capital Management’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding RGEN
UCFA
MC
WA
Legato Capital Management's RGEN Position: Q2 2026 in Review
Legato Capital Management reduced its Repligen (RGEN) stake by 12% in Q2 2026, selling an estimated $238K and leaving 14,562 shares worth $1.99M. The position accounts for 0.16% of the portfolio, ranked #188.
Legato Capital Management first reported a position in RGEN in Q2 2021 and has held it in 16 quarters since. The position peaked at $3.3M in Q4 2025. 481 funds tracked by Wall St. Rank hold RGEN as of Q2 2026.
- Legato Capital Management held 14,562 shares of Repligen worth $1.99M as of Q2 2026.
- Legato Capital Management sold 1,938 Repligen shares in Q2 2026, an estimated $238K.
- Repligen made up 0.16% of Legato Capital Management's portfolio in Q2 2026, its #188 holding.
- Legato Capital Management first reported a position in Repligen in Q2 2021 and has held it in 16 quarters since.
- Legato Capital Management's Repligen position peaked at $3.3M in Q4 2025.
- 481 funds tracked by Wall St. Rank held Repligen as of Q2 2026.
Based on Legato Capital Management's 13F filing for Q2 2026, filed 6 Aug 2026.